Host Mike Moore recently interviewed Acarix CEO, Aamir Mahmood. The company's CADScor®System is an advanced acoustic-based diagnostic aid to easily and quickly rule out significant coronary artery disease at point of care. As pointed out in this discussion, a number of clinical & economic value propositions exist for this technology, which will ultimately contribute to rapid adoption across multiple centers of care, starting with the Emergency Room.
Resources & Links
LinkedIn: Mike Moore
LinkedIn: The Bleeding Edge of Digital Health
Information
- Show
- FrequencyUpdated Biweekly
- PublishedJune 11, 2024 at 12:00 PM UTC
- Length31 min
- Season1
- Episode45
- RatingClean